A few recent studies have confirmed OPN haplotypes as modifiers of disease susceptibility in sarcoidosis, nephrolithiasis, pseudoxanthomaelasticum, gliomas, Crohn’s disease, and oral carcinogenesis [9, 13,14,15,16,17]. This evidence concerns the gene SPP1 and central nervous system cancer.